Synlife

Synlife was co-founded by MIT scientists in 2017. Headquartered in Cambridge, Massachusetts, the company is committed to innovating new therapeutic platforms through bottom-up engineering of synthetic cells. Our current focus is on encapsulating enzyme pathways as a means to achieve novel therapies.